Skip to main content
. 2023 Dec 19;16(1):18. doi: 10.3390/cancers16010018
KDR-V Kinase insert domain receptor Q472H
KDR-WT Kinase insert domain receptor Q472Q
ICI Immune checkpoint inhibitors
MVD Microvessel density
PFS Progression-free survival
TIL Tumor-infiltrating lymphocytes
FC Fold change
NK Natural killer